Cary Claiborne

Cary Claiborne

Directeur Général chez ADIAL PHARMACEUTICALS, INC.

Fortune : 176 521 $ au 31/05/2026

66 ans
Health Technology
Commercial Services
Finance

Profil

Cary J.
Claiborne
was the founder of Prosperity Capital Management LLC, founded in 2018, serving as Chief Executive Officer.
Current jobs include President, Chief Executive Officer & Director at Adial Pharmaceuticals, Inc. since 2022; Independent External Director at Neurosense Therapeutics Ltd. since 2021; and Director at Virginia Biotechnology Association since 2022.
Former jobs include President, CEO & Head-Investor Relations at New Generation Biofuels Holdings, Inc. from 2010; President, Chief Executive Officer & Director at New Generation Biofuels, Inc.; Director-Operations Analysis at General Electric Capital Corp.; Director at The Medicalert Foundation from 2013 to 2016; Independent Director at LadRx Corp.
from 2022 to 2025; Chief Financial Officer & Director at Indivior Ltd. from 2014 to 2017; Vice President-Financial Planning & Analysis at The Home Depot, Inc. from 2000 to 2001; Vice President-Financial Planning & Analysis at MCI, Inc. from 1997 to 2000; Chief Financial Officer & Secretary at Osiris Therapeutics, Inc. from 2004 to 2007; Vice President-Financial Planning & Analysis at Constellation Energy Group, Inc. from 2001 to 2004; Chief Financial Officer at Sucampo Pharmaceuticals LLC from 2011 to 2014; Chief Financial Officer at Reckitt Benckiser Pharmaceuticals, Inc.; Chief Financial Officer & Senior Vice President at GE Capital Business Processes Management Services Ltd. from 1982 to 1997; and Vice President-Financial Planning & Analysis at Manufacturers Components, Inc. from 1997 to 2020.
Education includes undergraduate studies at Rutgers State University of New Jersey and an MBA from Villanova University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
28/03/2026 207 898 ( 0,59% ) 170 684 $ 31/05/2026
07/04/2026 2 432 ( 0,11% ) 5 837 $ 31/05/2026
28/03/2025 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Cary Claiborne

SociétésPosteDébut
NEUROSENSE THERAPEUTICS LTD. Directeur/Membre du Conseil 01/11/2021
ADIAL PHARMACEUTICALS, INC. Directeur Général 18/08/2022
Directeur/Membre du Conseil 01/11/2022

Anciens postes connus de Cary Claiborne

SociétésPosteFin
LADRX CORPORATION Directeur/Membre du Conseil 28/07/2025
Corporate Officer/Principal 01/03/2020
Directeur Financier/CFO 01/02/2017
Directeur/Membre du Conseil 01/01/2016
SUCAMPO PHARMACEUTICALS, INC. Directeur Financier/CFO 08/11/2014
Voir l'expérience en détail de Cary Claiborne

Formation de Cary Claiborne

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

53

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées20

Finance

Retail Trade

Communications

Health Technology

Health Technology

Utilities

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Process Industries

Commercial Services

Health Technology

Commercial Services

New Generation Biofuels, Inc.

Commercial Services

Electronic Technology

Health Technology

Finance

  1. Bourse
  2. Insiders
  3. Cary Claiborne
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT